Early Cycle Ergometry for Critically-Ill Liver Failure Patients in a Transplant Intensive Care Unit
Liver Cirrhoses, Liver Failure, ICU Acquired Weakness
About this trial
This is an interventional treatment trial for Liver Cirrhoses focused on measuring Cycle Ergometry, Physical Therapy, Rehabilitation
Eligibility Criteria
Inclusion Criteria:
- Adults 18 ≥ years with acute or chronic liver disease admitted to Transplant Intensive Care Unit (TICU), or admitted to TICU following a liver or liver-kidney transplant
- Expected to remain in ICU for ≥ 5 days
- Spoken English fluency
Exclusion Criteria:
- Known primary systemic neuromuscular disease or intracranial process causing increased intracranial pressure
- Lower extremity amputation
- Anticipated death or palliative withdrawal of life support within 5 days
- Cycle ergometer weight limit (135 kg or 297.6 lbs per manufacturer)
Sites / Locations
- Medical College of Wisconsin
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Cycle Ergometry + Standard PT/OT
Standard PT/OT alone
The study intervention will include the same standard PT/OT procedures as the control arm (Standard PT/OT alone) with the addition of the Motomed Letto 2 lower extremity cycle ergometry sessions.
The control arm will involve standard PT/OT procedures that patients in the transplant intensive care unit receive routinely, with frequency to be determined by a physical and/or occupational therapist, and may include but are not limited to the following: Passive and active upper and lower extremity strength exercises, while in bed, sitting upright, and standing; stretching various muscle groups while supine in bed, sitting upright, and standing; in-bed mobility training including rolling and boosting; transfer training with and without an assistive device; gait training with and without an assistive device; balance exercises while sitting and standing; activities of daily living while sitting and standing; cognitive retraining